PEOPLE - Qiagen (Netherlands) makes appointment:
This article was originally published in Clinica
Dutch company Qiagen has appointed Dr Michael Burgett vice-president of its North American operations. Dr Burgett was most recently with Applied Imaging's genetic diagnostics division. Qiagen develops technologies and products focused on nucleic acid separation and purification.
You may also be interested in...
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.
Israel-based Binah.ai hopes to earn regulatory approval for a video-based monitoring app that can detect vital signs in minutes. See what Binah.ai's co-founder and CEO, David Maman, said about the technology here.
Top-level personnel movement continues at pharma firms in India, with Cipla now appointing an ex-Amneal executive as its Chief Scientific Officer, while Abbott has effected a rejig at the helm.